98%
921
2 minutes
20
Background: In modern workplaces, emotional well-being significantly impacts productivity, interpersonal relationships, and organizational stability. This study introduced an innovative facial-based emotion recognition system aimed at the real-time monitoring and management of employee emotional states.
Methods: Utilizing the RetinaFace model for facial detection, the Dlib algorithm for feature extraction, and VGG16 for micro-expression classification, the system constructed a 10-dimensional emotion feature vector. Emotional anomalies were identified using the K-Nearest Neighbors algorithm and assessed with a 3σ-based risk evaluation method.
Results: The system achieved high accuracy in emotion classification, as demonstrated by an empirical analysis, where VGG16 outperformed MobileNet and ResNet50 in key metrics such as accuracy, precision, and recall. Data augmentation techniques were employed to enhance the performance of the micro-expression classification model.
Conclusion: These techniques improved the across diverse emotional expressions, resulting in more accurate and robust emotion recognition. When deployed in a corporate environment, the system successfully monitored employees' emotional trends, identified potential risks, and provided actionable insights into early intervention. This study contributes to advancing corporate mental health management and lays the foundation for scalable emotion-based support systems in organizational settings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12035250 | PMC |
http://dx.doi.org/10.1177/20552076251335542 | DOI Listing |
Sci Bull (Beijing)
August 2025
Beijing Key Laboratory of Brainnetome and Brain-Computer Interface, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China; Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China; Xiaoxiang Institute for Brain Health and Yongzhou Central
Mol Psychiatry
September 2025
Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Increases in impulsivity and negative affect (e.g., neuroticism) are common during adolescence and are both associated with risk for alcohol-use initiation and other risk behaviors.
View Article and Find Full Text PDFAnn Epidemiol
September 2025
Veterans Health Administration- VA Tennessee Valley Health Care System Geriatric Research, Education and Clinical Center (GRECC), and VETWISE-LHS Center of Innovation, Nashville, TN; Vanderbilt-Ingram Cancer Center, Nashville, TN; Center for Clinical Quality and Implementation Research, Vanderbilt U
Purpose: Tobacco use is not commonly represented as computable information in the electronic health record (EHR). We developed an algorithm in the Veterans Health Administration (VHA) to identify tobacco ever-use among Veterans.
Methods: We used the VHA corporate data warehouse to develop an algorithm comprised of multiple data types (health factors [semi-structured template data entry and decision support tools], billing, orders, medication, and encounter codes) to identify tobacco ever-use (current or former) versus never use.
Alzheimers Dement
September 2025
Department of Psychiatry and The Behavioral Sciences, Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Introduction: Clinical Dementia Rating Sum of Boxes (CDR-SB) is a reliable and clinically meaningful composite for assessing treatment effects in Alzheimer's disease (AD) clinical trials. Small CDR-SB differences at the end of a trial often lead to controversy in deriving clinically meaningful interpretations.
Methods: We estimated progression-free time (PFT) participants remained at each 0.
Clin Nucl Med
September 2025
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea.
Background: Alzheimer disease (AD) is characterized by amyloid-β plaques (A), tau tangles (T), and neurodegeneration (N), collectively defining the ATN framework. While imaging biomarkers are well-established, the prognostic value of plasma biomarkers in predicting cognitive decline remains underexplored. This study compares plasma and imaging A/T/N biomarkers in predicting cognitive decline and evaluate the impact of combining biomarkers across modalities.
View Article and Find Full Text PDF